Hypothesis: Vitamin E Complements Polyunsaturated Fatty Acids in Essential Fatty Acid Deficiency in Cystic Fibrosis

REFERENCES

• Christophe A, Robberecht E: Current Knowledge on fatty acids in cystic fibrosis. Prostaglandins Leukot Essent Fatty Acids55 :129– 138,1996 .
   PubMed Web of Science ®Google Scholar
• Bezard J, Blond JP, Bernard A, Clouet P: The metabolism and availability of essential fatty acids in animal and human tissues. Reprod. Nutr Dev34 :539– 568,1994 .
   PubMedGoogle Scholar
• van Egmond AW, Kosorok MR, Koscik R, Laxova A, Farrell PM: Effect of linoleic acid intake on growth of infants with cystic fibrosis. Am J Clin Nutr63 :746– 752,1996 .
   PubMed Web of Science ®Google Scholar
• Pencharz PB, Durie PR: Nutritional Management of Cystic Fibrosis. Annu Rev Nutr13 :111– 136,1993 .
   PubMed Web of Science ®Google Scholar
• Farrell PM, Mischler EH, Engle MJ, Brown DJ, Lau S-M: Fatty acid abnormalities in cystic fibrosis. Pediatr Res19 :104– 109,1985 .
   PubMed Web of Science ®Google Scholar
• Biggemann B, Laryea MD, Schuster A, Griese M, Reinhardt D, Bremer HJ: Status of plasma and erythrocyte fatty acids and vitamin A and E in young children with cystic fibrosis. Scand J Gastroenterol23 :134– 141,1988 .
   PubMed Web of Science ®Google Scholar
• Levy E, Lepage G, Bendayan M: Relationship of decreased hepatic lipase activity and lipoprotein abnormalities to essential fatty acid deficiency in cystic fibrosis patients. J Lipid Res30 :1197– 1209,1989 .
   PubMed Web of Science ®Google Scholar
• Portal BC, Richard M-J, Faure HS, Hadjian AJ, Favier AE: Altered antioxidant status and increased lipid peroxidation in children with cystic fibrosis. Am J Clin Nutr61 :843– 847,1995 .
   PubMed Web of Science ®Google Scholar
• Parsons HG, O’Loughlin EV, Forbes D, Cooper D, Gall G: Supplemental calories improve essential fatty acid deficiency in cystic fibrosis patients. Pediatr Res24 :353– 356,1988 .
   PubMed Web of Science ®Google Scholar
• Dodge JA, O’Rawe AM: Nutritional aspects in cystic fibrosis. Eur J Gastroenterol Hepatol8 :739– 743,1996 .
   PubMed Web of Science ®Google Scholar
• Bhura-Bandali FN, Suh M, Man SFP, Clandinin MT: The deltaF508 mutation in the cystic fibrosis transmembrane conductance regulator alters control of essential fatty acid utilisation in epithelial cells. J Nutr130 :2870– 2875,2000 .
   PubMed Web of Science ®Google Scholar
• Lepage G, Champagne J, Ronco N, Lamarre A, Osberg I, Sokol RJ, Roy CC: Supplementation with carotenoids corrects increased lipid peroxidation in children with cystic fibrosis. Am J Clin Nutr64 :87– 93,1996 .
   PubMed Web of Science ®Google Scholar
• van der Vliet A, Eiserich JP, Marelich GP, Halliwell B, Cross CE: Oxidative stress in cystic fibrosis: does it occur and does it matter? Adv Pharmacol38 :491– 513,1997 .
   PubMedGoogle Scholar
• Wood LG, Collins CE, Garg ML: Oxidative stress and antioxidants in cystic fibrosis. In Basu TK, Temple NJ, Garg ML (eds): “Antioxidants in Human Health and Disease.” New York: CABI Publications, pp313– 333,1999 .
   Google Scholar
• Brown RK, Kelly FJ: Role of free radicals in the pathogenesis of cystic fibrosis. Thorax49 :738– 742,1994 .
   PubMed Web of Science ®Google Scholar
• Brown RK, Kelly FJ: Evidence for increased oxidative damage in patients with cystic fibrosis. Pediatr Res36 :487– 493,1994 .
   PubMed Web of Science ®Google Scholar
• Winklhofer-Roob BM, Puhl HP, Khoschsorur G, van’t Hof MA, Esterbauer H, Schmerling DH: Enhanced resistance to oxidation of low density lipoproteins and decreased lipid peroxide formation during beta-carotene supplementation in cystic fibrosis. Free Radic Biol Med18 :849– 859,1995 .
   PubMed Web of Science ®Google Scholar
• Kneepkens CMF, Ferreira C, Lepage G, Roy CC: Hydrocarbon breath test in cystic fibrosis: evidence for increased lipid peroxidation [Abstract]. J Pediatr Gastroenterol Nutr15 :344 ,1992 .
   Google Scholar
• Wood LG, Fitzgerald DA, Gibson PG, Cooper DM, Collins CE, Garg ML: Oxidative stress in cystic fibrosis: dietary and metabolic factors. J Am Coll Nutr20 :157– 165,2001 .
   PubMed Web of Science ®Google Scholar
• Montuschi P, Paredi P, Corradi M: 8-isoprostane, a biomarker of oxidative stress is increased in cystic fibrosis. Am J Respir Crit Care Med159 :A271 ,1999 .
   Google Scholar
• Sen CK: Oxygen toxicity and antioxidants: state of the art. Indian J Physiol Pharmacol39 :177– 196,1995 .
   PubMedGoogle Scholar
• MacDonald A: Nutritional management of cystic fibrosis. Arch Dis Child74 :81– 87,1996 .
   PubMed Web of Science ®Google Scholar
• Benabdeslam H, Abidi H, Garcia I, Bellon G, Gilly R, Revol A: Lipid peroxidation and antioxidant defences in cystic fibrosis. Clin Chem Lab Med37 :511– 516,1999 .
   PubMed Web of Science ®Google Scholar
• Benabdeslam H, Garcia I, Bellon G, Gilly R, Revol A: Biochemical assessment of the nutritional status of cystic fibrosis patients treated with pancreatic enzyme extracts. Am J Clin Nutr67 :912– 918,1998 .
   PubMed Web of Science ®Google Scholar
• Congden PJ, Bruce G, Rothburn MM: Vitamin status in treated patients with cystic fibrosis. Arch Dis Child56 :708– 714,1981 .
   PubMed Web of Science ®Google Scholar
• Dominguez C, Gartner S, Linan S, Cobos N, Moreno A: Enhanced oxidative damage in cystic fibrosis patients. Biofactors8 :149– 153,1998 .
   PubMed Web of Science ®Google Scholar
• Farrell PM, Bieri JG, Fratantoni JF, Wood RE, Di Sant’Agnese PA: The occurrence and effects of human vitamin E deficiency. A study of patients with cystic fibrosis. J Clin Invest60 :233– 241,1977 .
   PubMed Web of Science ®Google Scholar
• Willison HJ, Muller DPR, Matthews S, Jones S, Kriss A, Stead RJ, Hodson ME, Harding AE: A study of the relationship between neurological function and serum vitamin E concentrations in patients with cystic fibrosis. J Neurol Neurosurg Psychiatry48 :1097– 1102,1985 .
   PubMed Web of Science ®Google Scholar
• Winklhofer-Roob BM, van’t Hof MA, Schmerling DH: Long-term oral vitamin E supplementation in cystic fibrosis patients: RRR-alpha-tocopherol compared with all-rac-a-tocopheryl acetate preparations. Am J Clin Nutr63 :722– 728,1996 .
   PubMed Web of Science ®Google Scholar
• Winklhofer-Roob BM, Ziouzenkova O, Puhl H, Ellemunter H, Greiner P, Muller G, van’t Hof MA, Esterbauer H, Shmerling DH: Impaired resistance to oxidation of low density lipoprotein in cystic fibrosis: improvement during vitamin E supplementation. Free Radic Biol Med19 :725– 733,1995 .
   PubMed Web of Science ®Google Scholar
• Gibson RA, Teubner JK, Haines K, Cooper DM, Davidson GP: Relationship between pulmonary function and plasma fatty acid levels in cystic fibrosis patients. J Pediatr Gastroenterol Nutr5 :408– 415,1986 .
   PubMed Web of Science ®Google Scholar
• Roulet M, Frascarolo P, Rappaz I, Pilet M: Essential fatty acid deficiency in well nourished young cystic fibrosis patients. Eur J Pediatr156 :952– 956,1997 .
   PubMed Web of Science ®Google Scholar
• Yamamoto Y, Niki F, Eguchi J, Kamiya Y, Shimasaki H: Oxidation of biological membranes and its inhibition. Free radical chain oxidation of erythrocyte ghost membranes by oxygen. Biochim Biophys Acta819 :29– 36,1985 .
   PubMed Web of Science ®Google Scholar
• Bartoli GM, Giannatasio B, Palozza P, Cittadini A: Superoxide dismutase depletion and lipid peroxidation in rat liver carcinogenesis. Biochim Biophys Acta966 :214– 221,1988 .
   PubMed Web of Science ®Google Scholar
• Martin A: The use of antioxidants in healing. Dermatol Surg22 :156– 160,1996 .
   PubMed Web of Science ®Google Scholar
• Karlsson J: Exercise, muscle metabolism and the antioxidant defense. In Simopoulos AP, Pavlou KN (eds): “Nutrition and Fitness: Metabolic and Behavioral Aspects in Health and Disease. World Review of Food and Nutrition, Vol. 82.” Basel: Karger, pp81– 100,1997 .
   Google Scholar
• Ji LL: Exercise-induced modulation of antioxidant defense. Ann N Y Acad Sci959 :82– 92,2002 .
   PubMed Web of Science ®Google Scholar
• Sen CK: Antioxidants in exercise nutrition. Sports Med31 :891– 908,2001 .
   PubMed Web of Science ®Google Scholar
• Wood LG, Fitzgerald DA, Lee AK, Garg ML: Improved antioxidant and fatty acid status of patients with cystic fibrosis after antioxidant supplementation is linked to improved lung function. Am J Clin Nutr77 :150– 159,2003 .
   PubMed Web of Science ®Google Scholar
• Lloyd-Still JD, Ganther HE: Selenium and glutathione peroxidase levels in cystic fibrosis. Pediatrics65 :1010– 1012,1980 .
   PubMed Web of Science ®Google Scholar
• Chase HP, Dupont J: Abnormal levels of prostaglandins and fatty acids in blood of children with cystic fibrosis. Lancet2 :236– 238,1978 .
   PubMed Web of Science ®Google Scholar
• Mischler EH, Parrell SW, Farrell PM, Raynor WJ, Lemen RJ: Correction of linoleic acid deficiency in cystic fibrosis. Pediatr Res20 :36– 41,1986 .
   PubMed Web of Science ®Google Scholar
• Garg ML, Sebokova E, Thomson ABR, Clandinin MT: Delta-6 desaturase activity in liver microsomes of rats fed diets enriched with cholesterol and/or fatty acids. Biochem J249 :351– 356,1988 .
   PubMed Web of Science ®Google Scholar
• Kurlandsky LE, Bennink MR, Webb PM, Ulrich PJ, Baer LJ: The absorption and effect of dietary supplementation with omega-3 fatty acids on serum leukotriene B4 in patients with cystic fibrosis. Pediatr Pulmonol18 :211– 217,1994 .
   PubMed Web of Science ®Google Scholar
• Lawrence RH, Sorrell TC: Eicosapentaenoic acid modulates neutrophil leukotriene B4 receptor expression in cystic fibrosis. Clin Exp Immunol98 :12– 16,1994 .
   PubMed Web of Science ®Google Scholar
• Archer SL: Fish oil as a therapy for lung disease [Editorial]. Nutrition12 :372– 374,1996 .
   PubMed Web of Science ®Google Scholar
• Higdon JV, Liu J, Du S-H, Morrow JD, Ames BN, Wander RC: Supplementation of postmenopausal women with fish oil rich in eicosapentaenoic acid is not associated with greater in vivo lipid peroxidation compared with oils rich in oleate and linoleate as assessed by plasma malondialdehyde and F2-isoprostanes. Am J Clin Nutr72 :714– 722,2000 .
   PubMed Web of Science ®Google Scholar
• Garrido A, Garrido F, Guerra R, Valenzuela A: Ingestion of high doses of fish oil increases the susceptibility of cellular membranes to the induction of oxidative stress. Lipids24 :833– 835,1989 .
   PubMed Web of Science ®Google Scholar
• Harats D, Dabach Y, Hollander G: Fish oil ingestion in smokers enhances peroxidation of plasma lipoproteins. Atheroschlerosis90 :127– 139,1991 .
   PubMed Web of Science ®Google Scholar
• Meydani M, Natiello F, Goldin B: Effect of long-term fish oil supplementation on vitamin E status and lipid peroxidation in women. J Nutr121 :484– 491,1991 .
   PubMed Web of Science ®Google Scholar
• Mori TA, Dunstan DW, Burke V, Croft KD, Rivera JH, Beilin LJ, Puddey IB: Effect of dietary fish and exercise training on urinary F2-isoprostane excretion in non-insulin-dependent diabetic patients. Metabolism48 :1402– 1408,1999 .
   PubMed Web of Science ®Google Scholar
• Wander RC, Du SH, Ketchum SO, Rowe KE: Alpha-tocopherol influences in vivo indices of lipid peroxidation in postmenopausal women given fish oil. J Nutr126 :643– 652,1996 .
   PubMed Web of Science ®Google Scholar
• Quaggiotto P, Leitch J, Falconer J, Murdoch RN, Garg ML: Plasma F2alpha-isoprostane levels are lowered in pigs fed an n-3 polyunsaturated fatty acid supplemented diet following occlusion of the left anterior descending coronary artery. Nutr Res20 :675– 684,2000 .
   Web of Science ®Google Scholar
• Roberts 2nd LJ, Morrow JD: The generation and actions of isoprostanes. Biochim Biophys Acta1345 :121– 135,1997 .
   PubMed Web of Science ®Google Scholar
• Awad JA, Roberts 2nd LJ, Burk RF, Morrow JD: Isoprostanes-prostaglandin-like compounds formed in vivo independently of cyclooxygenase: use as clinical indicators of oxidant damage. Gastroenterol Clin N Amer25 :409– 427,1996 .
   PubMed Web of Science ®Google Scholar